Document is current
Any future updates will be listed below
-
Authors
Zotcheva, Ekaterina https://orcid.org/0000-0002-5777-4731
Strand, Bjørn Heine
Skirbekk, Vegard
Deckers, Kay
Krokstad, Steinar
Livingston, Gill
Singh-Manoux, Archana
Selbæk, Geir
-
Funding
Funding for this research was provided by:
Helse Sør-Øst RHF (2022053, 2022053)
Foundation for the National Institutes of Health (R01: R01AG069109-01, R01: R01AG069109-01)
European Research Council (101142786 – HOMME)
Vestfold Hospital Trust
- License Information
-
More Information
Article History
Received: 12 March 2025
Accepted: 10 April 2025
First Online: 22 April 2025
Declarations
:
: EZ, BHS, VS, KD, SK, GL and ASM declare no conflicts of interest. GS has participated in Advisory Board meetings for Roche, Eli-Lilly and Eisai regarding disease-modifying drugs for Alzheimer’s disease. GS has received honoraria for delivering lectures at symposia sponsored by Eisai and Eli-Lilly.
